Osaka, Japan

Akio Ozaki

This inventor holds 1 USPTO granted patent. Top assignee: Kanebo, Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akio Ozaki. Retrieved from https://idiyas.com/inventor/akio-ozaki-2hh5pi28

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akio Ozaki: Innovator in Antiemetic Research

Introduction

Akio Ozaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiemetic compounds. His work has been recognized for its potential impact on medical treatments.

Latest Patents

Ozaki holds a patent for a benzimidazole derivative, which is a process for preparing the same and serves as an antiemetic. This innovation showcases his expertise in medicinal chemistry and his commitment to improving patient care.

Career Highlights

He is currently employed at Kanebo, Limited, where he continues to engage in research and development. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his coworkers include Kenji Suzuki and Hiroshi Ohtaka, who contribute to the innovative environment at Kanebo, Limited. Their collective efforts enhance the research capabilities of the organization.

Conclusion

Akio Ozaki's contributions to the pharmaceutical industry, particularly through his patent on antiemetic compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…